REGAL REXNORD CORP·4

May 26, 5:07 PM ET

Rehard Robert 4

4 · REGAL REXNORD CORP · Filed May 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Regal Rexnord (RRX) CFO Robert Rehard Sells 6,499 Shares

What Happened

  • Robert Rehard, Executive Vice President and Chief Financial Officer of Regal Rexnord (RRX), sold 6,499 shares in an open-market transaction on May 22, 2026. The shares were disposed at $200.00 per share, for a total value of $1,299,800.
  • This was a sale (disposition) rather than a purchase or award; sales are often routine liquidity transactions and do not, by themselves, indicate a change in company outlook.

Key Details

  • Transaction date: 2026-05-22; Filing date (Form 4): 2026-05-26.
  • Price per share: $200.00; Total proceeds: $1,299,800.
  • Shares owned after transaction: Not disclosed in this filing.
  • Transaction type/code: Open market sale (S).
  • Notable footnotes in the filing:
    • F1: Describes a Stock Appreciation Rights vesting schedule (40% at year 2, up to 100% at year 5).
    • F2: Describes a different SAR vesting schedule (34% year 1, 67% year 2, 100% year 3).
  • Timeliness: The Form 4 was filed four days after the transaction; Form 4s are typically required within two business days (investors may want to note the filing date).

Context

  • This report documents a direct sale of shares. It does not show any option exercise or immediate sale following an exercise (i.e., no cashless exercise noted).
  • Insider sales can reflect many reasons (tax planning, diversification, routine sales), so this single sale should not be taken alone as a signal about company fundamentals.

Insider Transaction Report

Form 4
Period: 2026-05-22
Rehard Robert
EVP and CFO*
Transactions
  • Sale

    Common Stock

    2026-05-22$200.00/sh6,499$1,299,80027,964.953 total
Holdings
  • Stock Appreciation Rights

    [F1]
    Exercise: $76.99From: 2019-05-10Exp: 2027-05-10Common Stock (2,164 underlying)
    2,164
  • Stock Appreciation Rights

    [F1]
    Exercise: $74.04From: 2020-05-09Exp: 2028-05-09Common Stock (7,730 underlying)
    7,730
  • Stock Appreciation Rights

    [F1]
    Exercise: $78.05From: 2021-05-08Exp: 2029-05-08Common Stock (15,382 underlying)
    15,382
  • Stock Appreciation Rights

    [F2]
    Exercise: $84.39From: 2021-02-18Exp: 2030-02-18Common Stock (12,340 underlying)
    12,340
  • Stock Appreciation Rights

    [F2]
    Exercise: $133.77From: 2022-02-23Exp: 2031-02-23Common Stock (9,276 underlying)
    9,276
  • Stock Appreciation Rights

    [F2]
    Exercise: $151.27From: 2023-02-23Exp: 2032-02-23Common Stock (8,292 underlying)
    8,292
  • Stock Appreciation Rights

    [F2]
    Exercise: $154.20From: 2024-02-23Exp: 2033-02-23Common Stock (9,456 underlying)
    9,456
  • Stock Appreciation Rights

    [F2]
    Exercise: $168.47From: 2025-02-23Exp: 2034-02-23Common Stock (7,657 underlying)
    7,657
Footnotes (2)
  • [F1]The Stock Appreciation Rights vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant.
  • [F2]The Stock Appreciation Rights vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant.
Signature
/s/ Molly Johnson, as Power of Attorney|2026-05-26

Documents

1 file
  • 4
    wk-form4_1779829636.xmlPrimary

    FORM 4